EClinical Solution Market

EClinical Solution Market Size, Share & Trends Analysis Report

EClinical Solution Market Size, Share & Trends Analysis Report By Product (Safety Solutions, Randomization, And Trial Supply Management, Electronic Trail Master Files, Electronic Data Capture (EDC) And Clinical Data Management, Electronic Clinical Outcome Assessment, Clinical Trial Management Systems, Clinical Data Integration Platform, Clinical Analytics Platform) By Mode Of Delivery (Cloud-Based EClinical Solutions, On-Premise EClinical Solutions) By End-User (Hospitals, Medical Device Manufacturers, Academic Research Institutions, Consulting Service Companies, Contract Research Organizations) Based On Region, And Segment Forecasts, 2022 - 2028

Request Methodology

Download Sample

Published

Report ID : BMRC 1973

Number of pages : 300

Published Date : Nov 2022

Category : Healthcare

Delivery Timeline : 48 hrs

Pricing

Global eClinical Solution Market is valued at USD 8.12 Billion in 2021 and is expected to reach USD 19.69 Million by 2028 with a CAGR of 13.5% over the forecast period.

Global eClinical Solution Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2028- Increasing demand for eClinical solutions, rising integration of software solutions in clinical trials, and growing various technological advancements and improvements are some of the major factors driving the growth of the Global eClinical Solution Market.

Scope of Global eClinical Solution Market Report-

eClinical solutions are software and applications for efficient management of clinical trials and clinical research. Under the umbrella of e-Clinical Solutions, different software helps to manage, monitor, and record data as well as track deadlines with other features. Various eClinical measures include randomization and test supply management (RTSM), clinical trial management system (CTMS), and clinical data management system (CDMS). eClinical Solutions manage clinical technologies and skills to accelerate the clinical development process. eClinical solutions can be operated by web-based applications, installed on-premises, or deployed through cloud-based platforms. These measures validate and analyse clinical and operational data through integrated and advanced visualization and analytical techniques. As a result, they are widely used in hospitals, clinics, diagnostic centers, and other healthcare institutions.

Report Analysis	Details
Historical data	2018 - 2021
Forecast Period	2022 - 2028
Market Size in 2021:	USD 8.12 Billion
Base year considered	2021
Forecast Period CAGR %:	13.5%
Market Size Expected in 2028:	USD 19.69 Billion
Tables, Charts & Figures:	175
Pages	196
eClinical Solution Companies	Datatrak International, Inc., eClinical Solutions, IBM Watson Health, ERT Clinical, Bioclinica, Parexel International Corporation, Oracle, Dassault Systems, Anju Life Sciences Software, CRF Health, eClinicalWorks, and others.
Segments Covered	By Product, By Mode of Delivery, By End-User
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

The Covid-19 pandemic has shown a positive impact on the growth of the global eClinical solution market. During Covid-19 pandemic, number of biotechnological and pharmaceutical companies have focused their research and development efforts on supporting the development of the Covid-19 vaccine. Furthermore, due to the pandemic, many clinical trials adopted fully virtual/hybrid models, which significantly increased the demand for eClinical solutions.

Key Players of Global eClinical Solution Market Report-

Some major key players for the global eClinical solution market report cover prominent players like Datatrak International, Inc., eClinical Solutions, IBM Watson Health, ERT Clinical, Bioclinica, Parexel International Corporation, Oracle, Dassault Systems, Anju Life Sciences Software, CRF Health, eClinicalWorks, and others.

News-

eClinical Solutions Launched Elluminate Clinical Trial Management System (CTMS) for Faster Drug Development

On February 1^st, 2021; eClinical Solutions LLC announced the launch of the Illuminati Clinical Trial Management System (CTMS). Built on the Illuminate platform, which accelerates digitization and shortens clinical data review cycle times, the Illuminate CTMS now provides a source of truth for clinical operations data for faster and more informed decision making.

Oracle Launched a New Cloud-Based eClinical Solution

On February 9^th, 2018; Oracle announced the launch of a new comprehensive, unified cloud-based clinical solution aimed at bringing new drugs to market on time while maintaining quality and safety. The new """"Clinical One Platform"""" will combine clinical development operations and information with functions shared into a single environment and with an easy-to-use interface for sites, clinical coordinators, and their counterparts.

Increasing Number of Clinical Trials in the Pharmaceuticals and Biotechnology Industries, Rising Usage of eClinical Solutions by CROs, and Growing Focus Towards R & D Activities are Some of the Major Factors Driving the MarketGrowth

One of the major factors driving the growth of the eClinical solution market is the increasing number of clinical trials in the pharmaceuticals and biotechnology industries. Pharmaceutical and biotechnological organizations use eClinical measures to obtain regulatory approvals for newly developed drugs and medicines. The rising use of eClinical solutions in hospitals, medical device manufacturers, academic research institutions, consulting service companies, contract research organizations, and others is expected to drive the growth of the market. For instance; according to U.S. National Library of Medicine, there are about 417,550 clinical trials studies, including locations in all 50 states and 220 countries. As of March 2021, ClinicalTrials.gov received approximately 4.5 million monthly visitors.

In addition, the rising usage of eClinical solutions by CROs is also boosting the market growth. In order to reduce R&D costs by pharma and biotech companies, the increasing demand for outsourcing of clinical trials on various CROs will further drive the departmental growth, which will complement the market. Furthermore, clinical data management systems (CDMS) and electronic data capture (EDC) are the most prominent eClinical solutions adopted by various CROs to manage rising data volume. For instance; as per the news published, on February 2^nd, 2022; Castor launched CRO partnership program to increase the adoption of decentralized clinical trials. Moreover, the growing focus on R & D activities is another factor boosting the market growth. Developing a new drug is a long and complicated process, with the risk of failure at each stage. R & D From basic science to preclinical and clinical research to the approval of new treatments for patients is shared in a strong R & D ecosystem by industry, government, educational institutions and all other supplements play important role in bringing new medical advances to patients.

However, the high maintenance and implementation cost associated with eClinical solutions may hamper the growth of the global eClinical solution market. In spite of that, rising R&D for precision medicine may create more opportunities for the further growth of the market.

North America Holds a Major Share in the Global eClinical Solution Market

Geographically, North America is expected to dominate the global eClinical solution market within the forecast period due to the increasing prevalence of diabetes, rising clinical research activities, and the growing number of target populations in this region. The increasing prevalence of lifestyle-associated diseases such as diabetes and cardiac disorders are also boosting the market growth. For instance; according to the centers for disease control and prevention; in 2020, about 34.2 million people had diabetes in the United States. Rising clinical research activities also drives the market in this region. The rising clinical research activities have increased the demand for the eClinical solution market. For instance, as per the news published, on March 14^th, 2022; National Institutes of Health (NIH) has launched Phase 1 clinical trials evaluating three experimental HIV vaccines based on the Messenger RNA (mRNA) platform. The technology is used in a number of recognized Covid-19 vaccines.

The Asia Pacific is the fastest-growing region in the global eClinical solution market due to the increasing incidence of targeting chronic diseases such as cardiovascular conditions, cancer, & infectious diseases and maintaining outsourcing of clinical trials in this region. The increasing incidences of targeting chronic diseases such as cardiovascular conditions, cancer, and infectious diseases are also boosting the market growth. For instance; according to the Times of India, on January 7^th, 2021; there are about 75 million people over the age of 60 in India suffer from some form of chronic illness.

Global eClinical Solution Market Segmentation:

By Product

Safety Solutions
Randomization and Trial Supply Management (RTMS)
Electronic Trail Master Files (eTMF)
Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
Electronic Clinical Outcome Assessment (eCOA)
Clinical Trial Management Systems (CTMS)
Clinical Data Integration Platform
Clinical Analytics Platform

By Mode of Delivery

Cloud-based eClinical Solutions
On-premise eClinical Solutions

By End-User

Hospitals
Medical Device Manufacturers
Academic Research Institutions
Consulting Service Companies
Contract Research Organizations
Others